CClinicalTrials.gg
CompletedNCT01702077Updated Aug 27, 2018

Neurofeedback for Tourette Syndrome

An interventional study of Neurofeedback and Sham feedback in Tourette Syndrome and Chronic Tic Disorder, sponsored by Yale University. Completed at 1 site in United States. Open to participants aged 11 Years to 19 Years. Per ClinicalTrials.gov, last updated 2018-08-27.

Sponsored by Yale University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Randomized
Ages
11 Years to 19 Years
Sex
All
01

Study summary

The aim of this study is to train patients with tic disorders to control activity in a region of their brain that has been associated with the urge to tic. Patients will be given direct feedback regarding activity in this brain area while they are undergoing functional magnetic resonance imaging (fMRI) scanning, and will try to learn to control activity in the region during these feedback sessions. In separate sessions, patients will be given sham feedback based on the brain patterns of a prior subject rather than their own brain patterns. Our primary hypothesis is that the biofeedback training will reduce their tic symptoms more than the sham feedback.

02

Conditions studied

  • Tourette Syndrome
  • Chronic Tic Disorder

Keywords

  • neurofeedback
  • biofeedback
  • real-time fMRI
  • rt-fMRI
  • functional connectivity
  • fMRI
03

In context

Tourette Syndrome

220 studies on the registry are indexed under Tourette Syndrome; 37 are open to participants now.

This study's enrollment of 21 is below the median of 34 across 166 interventional studies indexed under Tourette Syndrome.

Browse Tourette Syndrome studies →

Lead sponsor

Yale University is the lead sponsor of 1,724 studies on the registry; 298 are open to participants now.

Of its 210 completed or terminated interventional studies of FDA-regulated products, 126 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosis of Tourette Syndrome or Chronic Tic Disorder
  • currently active tics
  • aged 11-19
  • ability to execute most common tics without moving head while lying on back

Exclusion criteria

Exclusion Criteria:

  • Blindness (because feedback is provided visually)
  • Lifetime diagnosis of pervasive developmental disorder, bipolar disorder, or psychotic disorder.
  • Presence of any serious psychiatric or psychosocial condition requiring initiation of new treatment or change in current treatment.
  • Neurological conditions affecting central nervous system, with the exception that predisposition to migraine will not be grounds for exclusion
  • Change in medication in the month prior to beginning the study
  • Unwillingness to keep medication stable over the course of the intervention
  • Full braces (but some retainers are OK)
  • Claustrophobia of a degree that they cannot comfortably be scanned
  • If common tics involve dramatic changes in breathing that could alter blood oxygenation measurements
  • Inability to keep head still while executing most common tics
  • Inability to keep head still in mock scanner
  • Inability or unwillingness to understand or follow the instructions
  • Pregnancy or possible pregnancy
  • Subjects may also be excluded after the first magnetic resonance scan if we are unable to localize a region of their supplementary motor area involved in tics - leaving us without a target area for biofeedback.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
21 participants (actual)

Study arms

  • Experimental
    Neurofeedback first

    Neurofeedback then sham feedback

    Procedure: Neurofeedback · Procedure: Sham feedback

  • Experimental
    Sham first

    Sham feedback then neurofeedback

    Procedure: Neurofeedback · Procedure: Sham feedback

Interventions

  • ProcedureNeurofeedback

    Also known as: biofeedback, real-time fMRI biofeedback

  • ProcedureSham feedback
06

What researchers measure

Primary outcomes

  1. Tic severity

    A modified version of the Yale Global Tic Severity Scale (YGTSS) will be used, that queries subjects regarding symptoms over the last 3 days (rather than the 2 week period used in the standard scale). Total YGTSS score on this modified scale will be used as the measure of tic severity.

    Time frame: Tic severity assessed approximately half a week PRIOR TO beginning biofeedback/sham feedback.

  2. Tic severity

    A modified version of the Yale Global Tic Severity Scale (YGTSS) will be used, that queries subjects regarding symptoms over the last 3 days (rather than the 2 week period used in the standard scale). Total YGTSS score on this modified scale will be used as the measure of tic severity.

    Time frame: Tic severity assessed approximately half a week AFTER completing biofeedback/sham feedback.

Secondary outcomes

  1. Control over target brain area

    Control task scans will be conducted in which subjects are cued to alternately increase and decrease activity in their target area without receiving any feedback. The percent signal change in the BOLD signal in the target area during increase relative to decrease blocks will be used as the measure of control over the brain area.

    Time frame: Assessed approximately half a week BEFORE biofeedback/sham biofeedback.

  2. Control over target brain area

    Control task scans will be conducted in which subjects are cued to alternately increase and decrease activity in their target area without receiving any feedback. The percent signal change in the BOLD signal in the target area during increase relative to decrease blocks will be used as the measure of control over the brain area.

    Time frame: Assessed approximately half a week AFTER biofeedback/sham biofeedback.

Other outcomes

  1. Functional connectivity patterns in the brain

    Functional connectivity will be assessed based on temporal correlations in resting state functional imaging data.

    Time frame: Assessed approximately half a week BEFORE biofeedback/sham biofeedback.

  2. Functional connectivity patterns in the brain

    Functional connectivity will be assessed based on temporal correlations in resting state functional imaging data.

    Time frame: Assessed approximately half a week AFTER biofeedback/sham biofeedback.

  3. Clinical improvement

    The Clinical Global Impression - Improvement scale will be used to assess improvement over the course of the biofeedback/sham feedback

    Time frame: Clinical improvement will be assessed approximately half a week AFTER biofeedback/sham feedback

07

Study locations

1 site
  • Yale University School of Medicine
    New Haven, Connecticut 06520, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 27, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01702077
Lead sponsor
Yale University
Collaborators
National Institute of Mental Health (NIMH)
Responsible party
Sponsor
First posted
Oct 5, 2012
Start date
Oct 2012
Primary completion
Dec 2017
Completion
Dec 2017
Last update
Aug 27, 2018

Study contacts

Michelle Hampson, Ph.D.
principal investigator · Yale University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion